{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:20:36Z","timestamp":1772119236201,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","award":["A-11627"],"award-info":[{"award-number":["A-11627"]}],"id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"crossref","award":["1229721N"],"award-info":[{"award-number":["1229721N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","award":["FFB210050"],"award-info":[{"award-number":["FFB210050"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00259-024-06880-x","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T03:02:25Z","timestamp":1724727745000},"page":"122-133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Preclinical evaluation of the novel [18F]CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington's disease"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5410-687X","authenticated-orcid":false,"given":"Franziska","family":"Zajicek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4493-1902","authenticated-orcid":false,"given":"Jeroen","family":"Verhaeghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5307-3575","authenticated-orcid":false,"given":"Stef","family":"De Lombaerde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6488-5456","authenticated-orcid":false,"given":"Annemie","family":"Van Eetveldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5381-015X","authenticated-orcid":false,"given":"Alan","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Munoz-Sanjuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2175-5117","authenticated-orcid":false,"given":"Vinod","family":"Khetarpal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5097-1361","authenticated-orcid":false,"given":"Jonathan","family":"Bard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3995-0196","authenticated-orcid":false,"given":"Longbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3376-0519","authenticated-orcid":false,"given":"Steven","family":"Staelens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4205-5432","authenticated-orcid":false,"given":"Daniele","family":"Bertoglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"6880_CR1","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou F, Humbert S. The biology of huntingtin. Neuron. 2016;89:910\u201326. https:\/\/doi.org\/10.1016\/j.neuron.2016.02.003.","journal-title":"Neuron"},{"key":"6880_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-e","volume":"72","author":"The-Huntington\u2019s-Disease-Collaborative-Research-Group","year":"1993","unstructured":"The-Huntington\u2019s-Disease-Collaborative-Research-Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell. 1993;72:971\u201383. https:\/\/doi.org\/10.1016\/0092-8674(93)90585-e.","journal-title":"Cell"},{"key":"6880_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/7854_2014_354","volume":"22","author":"HJ Waldvogel","year":"2015","unstructured":"Waldvogel HJ, Kim EH, Tippett LJ, Vonsattel JP, Faull RL. The neuropathology of huntington\u2019s disease. Curr Top Behav Neurosci. 2015;22:33\u201380. https:\/\/doi.org\/10.1007\/7854_2014_354.","journal-title":"Curr Top Behav Neurosci"},{"key":"6880_CR4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","volume":"101","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi SJ, Ghosh R, Leavitt BR. Huntingtin lowering strategies for disease modification in huntington\u2019s disease. Neuron. 2019;101:801\u201319. https:\/\/doi.org\/10.1016\/j.neuron.2019.01.039.","journal-title":"Neuron"},{"key":"6880_CR5","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/s1474-4422(17)30280-6","volume":"16","author":"EJ Wild","year":"2017","unstructured":"Wild EJ, Tabrizi SJ. Therapies targeting DNA and RNA in Huntington\u2019s disease. Lancet Neurol. 2017;16:837\u201347. https:\/\/doi.org\/10.1016\/s1474-4422(17)30280-6.","journal-title":"Lancet Neurol"},{"key":"6880_CR6","doi-asserted-by":"publisher","first-page":"e0189891","DOI":"10.1371\/journal.pone.0189891","volume":"12","author":"DJ Hensman Moss","year":"2017","unstructured":"Hensman Moss DJ, Robertson N, Farmer R, Scahill RI, Haider S, Tessari MA, et al. Quantification of huntingtin protein species in Huntington\u2019s disease patient leukocytes using optimised electrochemiluminescence immunoassays. PLoS ONE. 2017;12:e0189891. https:\/\/doi.org\/10.1371\/journal.pone.0189891.","journal-title":"PLoS ONE"},{"key":"6880_CR7","doi-asserted-by":"publisher","first-page":"e96854","DOI":"10.1371\/journal.pone.0096854","volume":"9","author":"D Macdonald","year":"2014","unstructured":"Macdonald D, Tessari MA, Boogaard I, Smith M, Pulli K, Szynol A, et al. Quantification assays for total and polyglutamine-expanded huntingtin proteins. PLoS ONE. 2014;9:e96854. https:\/\/doi.org\/10.1371\/journal.pone.0096854.","journal-title":"PLoS ONE"},{"key":"6880_CR8","doi-asserted-by":"publisher","first-page":"e0213521","DOI":"10.1371\/journal.pone.0213521","volume":"14","author":"W Reindl","year":"2019","unstructured":"Reindl W, Baldo B, Schulz J, Janack I, Lindner I, Kleinschmidt M, et al. Meso scale discovery-based assays for the detection of aggregated huntingtin. PLoS ONE. 2019;14:e0213521. https:\/\/doi.org\/10.1371\/journal.pone.0213521.","journal-title":"PLoS ONE"},{"key":"6880_CR9","doi-asserted-by":"publisher","first-page":"8608","DOI":"10.1021\/acs.jmedchem.0c00955","volume":"63","author":"L Liu","year":"2020","unstructured":"Liu L, Prime ME, Lee MR, Khetarpal V, Brown CJ, Johnson PD, et al. Imaging mutant huntingtin aggregates: development of a potential PET ligand. J Med Chem. 2020;63:8608\u201333. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00955.","journal-title":"J Med Chem"},{"key":"6880_CR10","doi-asserted-by":"publisher","first-page":"12003","DOI":"10.1021\/acs.jmedchem.1c00667","volume":"64","author":"L Liu","year":"2021","unstructured":"Liu L, Johnson PD, Prime ME, Khetarpal V, Lee MR, Brown CJ, et al. [(11)C]CHDI-626, a PET tracer candidate for imaging mutant huntingtin aggregates with reduced binding to AD pathological proteins. J Med Chem. 2021;64:12003\u201321. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00667.","journal-title":"J Med Chem"},{"key":"6880_CR11","doi-asserted-by":"publisher","first-page":"17977","DOI":"10.1038\/s41598-021-97334-z","volume":"11","author":"F Herrmann","year":"2021","unstructured":"Herrmann F, Hessmann M, Schaertl S, Berg-Rosseburg K, Brown CJ, Bursow G, et al. Pharmacological characterization of mutant huntingtin aggregate-directed PET imaging tracer candidates. Sci Rep. 2021;11:17977. https:\/\/doi.org\/10.1038\/s41598-021-97334-z.","journal-title":"Sci Rep"},{"key":"6880_CR12","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1007\/s00259-021-05578-8","volume":"49","author":"D Bertoglio","year":"2022","unstructured":"Bertoglio D, Verhaeghe J, Miranda A, Wyffels L, Stroobants S, Mrzljak L, et al. Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington\u2019s disease. Eur J Nucl Med Mol Imaging. 2022;49:1166\u201375. https:\/\/doi.org\/10.1007\/s00259-021-05578-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6880_CR13","doi-asserted-by":"publisher","first-page":"eabm3682","DOI":"10.1126\/scitranslmed.abm3682","volume":"14","author":"D Bertoglio","year":"2022","unstructured":"Bertoglio D, Bard J, Hessmann M, Liu L, Gartner A, De Lombaerde S, et al. Development of a ligand for in vivo imaging of mutant huntingtin in Huntington\u2019s disease. Sci Transl Med. 2022;14:eabm3682. https:\/\/doi.org\/10.1126\/scitranslmed.abm3682.","journal-title":"Sci Transl Med"},{"key":"6880_CR14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265569","author":"D Bertoglio","year":"2023","unstructured":"Bertoglio D, Weiss AR, Liguore W, Martin LD, Hobbs T, Templon J, et al. In vivo cerebral imaging of mutant huntingtin aggregates using (11)C-CHDI-180R PET in a nonhuman primate model of huntington disease. J Nucl Med. 2023. https:\/\/doi.org\/10.2967\/jnumed.123.265569.","journal-title":"J Nucl Med"},{"key":"6880_CR15","unstructured":"Burns HD, Hamill TG, Eng W-S, Hargreaves R. Annual Reports In Medicinal Chemistry - Section VI - Topics in Drug Design and Discovery. United States of America: Academic Press; 2001."},{"key":"6880_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41181-016-0018-0","volume":"1","author":"S Li","year":"2017","unstructured":"Li S, Schmitz A, Lee H, Mach RH. Automation of the Radiosynthesis of Six Different (18)F-labeled radiotracers on the AllinOne. EJNMMI Radiopharm Chem. 2017;1:15. https:\/\/doi.org\/10.1186\/s41181-016-0018-0.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"6880_CR17","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c01585","author":"L Liu","year":"2022","unstructured":"Liu L, Johnson PD, Prime ME, Khetarpal V, Brown CJ, Anzillotti L, et al. Design and evaluation of [(18)F]CHDI-650 as a positron emission tomography ligand to image mutant huntingtin aggregates. J Med Chem. 2022. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01585.","journal-title":"J Med Chem"},{"key":"6880_CR18","doi-asserted-by":"publisher","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled LB, Kudwa AE, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, et al. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175. PLoS ONE. 2012;7:e49838. https:\/\/doi.org\/10.1371\/journal.pone.0049838.","journal-title":"PLoS ONE"},{"key":"6880_CR19","doi-asserted-by":"publisher","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","volume":"7","author":"T Heikkinen","year":"2012","unstructured":"Heikkinen T, Lehtimaki K, Vartiainen N, Puolivali J, Hendricks SJ, Glaser JR, et al. Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease. PLoS ONE. 2012;7:e50717. https:\/\/doi.org\/10.1371\/journal.pone.0050717.","journal-title":"PLoS ONE"},{"key":"6880_CR20","doi-asserted-by":"publisher","first-page":"e69782","DOI":"10.1371\/journal.pone.0069782","volume":"8","author":"C Cudalbu","year":"2013","unstructured":"Cudalbu C, McLin VA, Lei H, Duarte JM, Rougemont AL, Oldani G, et al. The C57BL\/6J mouse exhibits sporadic congenital portosystemic shunts. PLoS ONE. 2013;8:e69782. https:\/\/doi.org\/10.1371\/journal.pone.0069782.","journal-title":"PLoS ONE"},{"key":"6880_CR21","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s11307-019-01435-1","volume":"22","author":"D Bertoglio","year":"2020","unstructured":"Bertoglio D, Verhaeghe J, Korat S, Miranda A, Wyffels L, Stroobants S, et al. In vitro and in vivo assessment of suitable reference region and kinetic modelling for the mGluR1 radioligand [(11)C]ITDM in Mice. Mol Imaging Biol. 2020;22:854\u201363. https:\/\/doi.org\/10.1007\/s11307-019-01435-1.","journal-title":"Mol Imaging Biol"},{"key":"6880_CR22","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1177\/0271678X19864081","volume":"40","author":"D Bertoglio","year":"2020","unstructured":"Bertoglio D, Verhaeghe J, Miranda A, Kertesz I, Cybulska K, Korat S, et al. Validation and noninvasive kinetic modeling of [(11)C]UCB-J PET imaging in mice. J Cereb Blood Flow Metab. 2020;40:1351\u201362. https:\/\/doi.org\/10.1177\/0271678X19864081.","journal-title":"J Cereb Blood Flow Metab"},{"key":"6880_CR23","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3389\/fneur.2018.00516","volume":"9","author":"J Verhaeghe","year":"2018","unstructured":"Verhaeghe J, Bertoglio D, Kosten L, Thomae D, Verhoye M, Van Der Linden A, et al. Noninvasive relative quantification of [(11)C]ABP688 PET imaging in mice versus an input function measured over an arteriovenous shunt. Front Neurol. 2018;9:516. https:\/\/doi.org\/10.3389\/fneur.2018.00516.","journal-title":"Front Neurol"},{"key":"6880_CR24","doi-asserted-by":"publisher","first-page":"045001","DOI":"10.1088\/2057-1976\/ab8c13","volume":"6","author":"A Miranda","year":"2020","unstructured":"Miranda A, Bertoglio D, Glorie D, Stroobants S, Staelens S, Verhaeghe J. Validation of a spatially variant resolution model for small animal brain PET studies. Biomed Phys Eng Express. 2020;6:045001. https:\/\/doi.org\/10.1088\/2057-1976\/ab8c13.","journal-title":"Biomed Phys Eng Express"},{"key":"6880_CR25","doi-asserted-by":"publisher","first-page":"e0206613","DOI":"10.1371\/journal.pone.0206613","volume":"13","author":"D Bertoglio","year":"2018","unstructured":"Bertoglio D, Verhaeghe J, Kosten L, Thomae D, Van der Linden A, Stroobants S, et al. MR-based spatial normalization improves [18F]MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington\u2019s disease. PLoS ONE. 2018;13:e0206613. https:\/\/doi.org\/10.1371\/journal.pone.0206613.","journal-title":"PLoS ONE"},{"key":"6880_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.neuroimage.2010.06.067","volume":"53","author":"GA Johnson","year":"2010","unstructured":"Johnson GA, Badea A, Brandenburg J, Cofer G, Fubara B, Liu S, et al. Waxholm space: an image-based reference for coordinating mouse brain research. Neuroimage. 2010;53:365\u201372. https:\/\/doi.org\/10.1016\/j.neuroimage.2010.06.067.","journal-title":"Neuroimage"},{"key":"6880_CR27","doi-asserted-by":"crossref","unstructured":"Cicchetti D. Guidlines, criteria, and rules of thum for evaluating nomred and standardized assessment instruments in psychology. Psychol Assess. 1994;6:284\u201390. 1040\u20133590\/94\/53.00.","DOI":"10.1037\/\/1040-3590.6.4.284"},{"key":"6880_CR28","doi-asserted-by":"publisher","unstructured":"Kaur T, Brooks AF, Lapsys A, Desmond TJ, Stauff J, Arteaga J, et al. Synthesis and evaluation of a fluorine-18 radioligand for imaging Huntingtin aggregates by positron emission tomographic imaging. Front Neurosci. 2021;15. https:\/\/doi.org\/10.3389\/fnins.2021.766176.","DOI":"10.3389\/fnins.2021.766176"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-06880-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-024-06880-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-06880-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T04:06:20Z","timestamp":1732593980000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-024-06880-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["6880"],"URL":"https:\/\/doi.org\/10.1007\/s00259-024-06880-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.05.16.594492","asserted-by":"object"}]},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"22 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Experiments followed the European Committee (decree 2010\/63\/CEE) and were approved by the Ethical Committee for Animal Testing (ECD 2019\u201339) at the University of Antwerp (Belgium).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"IMS, CD, VK, JB, and LL are employed by CHDI Management, Inc. the company that manages the scientific activities of CHDI Foundation, Inc. No other potential conflicts of interest relevant to this article exist.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}